Source: Clinical Kidney Journal. Unidade: FMRP
Subjects: IMUNOGENICIDADE DA VACINA, CORONAVIRUS, VACINAÇÃO
ABNT
PESTANA, Jose Osmar Medina et al. Clinical impact, reactogenicity and immunogenicity after the first CoronaVac dose in dialysis patients [Carta]: a Phase IV prospective study. Clinical Kidney Journal. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/ckj/sfab146. Acesso em: 29 jan. 2026. , 2021APA
Pestana, J. O. M., Teixeira, C. M., Cristelli, M. P., Amiratti, A. L., Manfredi, S. R., Silva Junior, H. T., & Covas, D. T. (2021). Clinical impact, reactogenicity and immunogenicity after the first CoronaVac dose in dialysis patients [Carta]: a Phase IV prospective study. Clinical Kidney Journal. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/ckj/sfab146NLM
Pestana JOM, Teixeira CM, Cristelli MP, Amiratti AL, Manfredi SR, Silva Junior HT, Covas DT. Clinical impact, reactogenicity and immunogenicity after the first CoronaVac dose in dialysis patients [Carta]: a Phase IV prospective study [Internet]. Clinical Kidney Journal. 2021 ; 14( 12): 2612-2615.[citado 2026 jan. 29 ] Available from: https://doi.org/10.1093/ckj/sfab146Vancouver
Pestana JOM, Teixeira CM, Cristelli MP, Amiratti AL, Manfredi SR, Silva Junior HT, Covas DT. Clinical impact, reactogenicity and immunogenicity after the first CoronaVac dose in dialysis patients [Carta]: a Phase IV prospective study [Internet]. Clinical Kidney Journal. 2021 ; 14( 12): 2612-2615.[citado 2026 jan. 29 ] Available from: https://doi.org/10.1093/ckj/sfab146
